Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient treatment and parental work absences in Europe, ...

Costs varied across 5 European countries, driven primarily by repeated primary care visits and parental work absences.

The agency told vaccine makers that COVID-19 vaccines used in the United States starting in fall 2025 should be based on JN.1 ...

As the mercury drops and we start reaching for our scarves and slippers, there’s another reason to brace ourselves this ...

Medicare Part B and Part D cover all out-of-pocket costs for common vaccines, including vaccines for the flu, pneumonia, ...

SRIKAKULAM: The fate of tenant farmers remains unchanged as Crop Cultivators’ Rights Cards (CCRCs) are still not being issued ...

AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. The antibody ...

The Trump administration released a 72-page report Thursday outlining its take on what's driving "a chronic disease crisis" ...